Pfizer and BioNTech Statement: 3 Vaccine Doses Neutralize Omicron Strain

Pfizer and BioNTech have announced the effectiveness of their vaccine against the Omicron coronavirus strain when three doses are given.

As shown by the preliminary results of the study, after the third dose, the required level of neutralizing antibodies to the Omicron-variant is reached, with reference to the company’s press release, TASS reports:

“Preliminary data show that the third dose elicits a similar level of neutralizing antibodies to the Omicron variant as seen after two doses against other strains that occurred before it.”

At two doses, the effectiveness of the vaccine against the new strain is much lower:

“The neutralizing potential is reduced by more than 25 times. This indicates that two doses of BNT162b2 do not provide sufficient protection against omicron strain contamination.”

Ugur ahin, head of BioNTech, explains that booster vaccinations can provide sufficient protection against any severity of disease caused by the Omicron variant.





Source link

High-quality journalistic work cannot be free, otherwise it becomes dependent on the authorities or the oligarchs.
Our site is solely funded by advertising money.
Please disable your ad blocker to continue reading the news.
Best regards, editors